Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Bionomy Health vs HealthSource

Bionomy Health
Graded #182

Lower grade

vs+4.6000000000000085
HealthSource
Graded #96

Higher grade

The verdict

HealthSource takes it — 71.2/100 to 66.6/100.

HealthSource grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthSource is a telehealth weight-management platform offering compounded semaglutide and tirzepatide (injectable and oral sublingual) dispensed through a US-based FDA 503A licensed partner pharmacy.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHealthSource +19
47
66
Dose & formulationHealthSource +8
75
83
Clinical oversightHealthSource +2
78
80
Labs & monitoringBionomy Health +8
62
54
FulfillmentBionomy Health +9
89
80
Contract termsHealthSource +2
53
55
Bionomy Health · left barHealthSource · right bar

The numbers

MetricBionomy HealthHealthSource
WeighScore66.6/10071.2/100
GradeCC
Scorecard rank#182#96
Semaglutide$189/mo (starting dose, compounded)$199/mo (all doses, compounded)
Tirzepatide$249/mo (compounded)$299/mo (all doses, compounded)
Coverage48 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Bionomy Health

Graded #182 · C

Strengths

  • Cancellation is genuinely unconditional: no subscription, no card on file, no auto-renewal, no cancellation fee — you pay per refill
  • Prices are published before intake on a dedicated GLP-1 page, and the same figures appear in the site's own llms.txt
  • Available in 48 states

Where it loses points

  • The $189 is a starting rate, not a flat one: the page says 'From', the product card says 'Starter', and doses are titrated every four weeks with no published price for the dose you end up on
  • The homepage says muscle preservation is 'included' while the GLP-1 page sells a Muscle Preserve Pack at $109/mo as a separate line item
  • No FDA-approved pathway and no oral route — the site does not mention Wegovy, Ozempic, Zepbound or Mounjaro at all
  • Not available in Alaska or Hawaii
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products
HealthSource

Graded #96 · C

Strengths

  • Three GLP-1 options: compounded semaglutide injection, tirzepatide injection, and oral sublingual tirzepatide
  • 24/7 access to care team via HIPAA-compliant platform with unlimited physician messaging
  • Every program covers the cost of medication, supplies, and telehealth visits — no separate pharmacy fee
  • Subscription auto-refund if monthly reassessment is not completed
  • Available in all 50 US states including Alaska and Hawaii with 3–5 day shipping

Where it loses points

  • No physician names or clinical leadership disclosed on public pages
  • No LegitScript certification found
  • 503A partner pharmacy not named — less transparent than providers disclosing their 503B pharmacy
  • Labs not mentioned on any product page — baseline bloodwork protocol unknown
  • WooCommerce e-commerce storefront may feel more transactional than clinical

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard